Vyzulta 0.024% Ophthalmic Solution (Latanoprostene Bunod), 5ml Ldpe Dropper Bottle

The product description information listed above is indicative only and sourced from the product manufacturer and/or supplier. It may be possible that the product information is incomplete or inaccurate in certain respects. It is therefore recommended that you use the product description information as a guide, but that you verify the more detailed information in relation to the product upon physical receipt. This would include information on matters such as proper application, potential side-effects, ingrediants and any application/usage guidelines or warning. In the event you have any queries or concerns in relation to the product please contact one of our pharmacists in store or call 800BINSINA for more advice

• The recommended dose is one drop in the conjunctival sac of the affected eye(s) once daily in the evening.

• VYZULTATM (latanoprostene bunod ophthalmic solution), 0.024%, is a new innovative molecule indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension